NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

A $4 to $20 billion apples to pineapples question?

Genmab is already a roughly $20 billion company. (Anchor that price everyone!)

It’s a development and commercialization deal worth almost $4 Billion for 3 early stage bispecific antibodies for blood cancers that haven’t even made it to phase 1 trials.

I thought it was a generous deal, given GMAB shares profits 50:50 in US and Japan, potentially worth billions, and gets up to 26% royalties from ABBV using its muscle and worldwide network of blond drug reps to sell to the rest of the world.